Abstract
Aim: This study aimed to evaluate how 99mTc-Pertechnetate scintigraphy informed 131I therapy (RAI) dose determination in treating feline
hyperthyroidism. 131I dose determination was calculated based on the percentage uptake and adjusted using a morphology based weighting factor
hyperthyroidism. 131I dose determination was calculated based on the percentage uptake and adjusted using a morphology based weighting factor
Original language | English |
---|---|
Pages | 49-50 |
Number of pages | 2 |
Publication status | Published - 2024 |
Event | 54th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine 2024: ANZSNM ASM 2024 - Christchurch, New Zealand Duration: 25 Apr 2024 → 28 Apr 2024 https://onlinelibrary.wiley.com/toc/14455994/2024/54/S2 (Proceedings) |
Conference
Conference | 54th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine 2024 |
---|---|
Abbreviated title | Discover the nucleus |
Country/Territory | New Zealand |
City | Christchurch |
Period | 25/04/24 → 28/04/24 |
Internet address |
|